PPARA and breast carcinoma: [136] On the other hand, m6A modified lncDBET in bladder cancer (BCa) and lncRNA CCAT1 in LUAD can both interact with FABP5 directly to activate the PPAR signaling pathway or PPAR‐RXR transcriptional complex in order to promote lipogenesis, proliferation and migration of cancers.[137, 138] Additionally, circ_ZFR in breast cancer (BC) and circPUM1 in clear cell renal cell carcinoma (ccRCC) can both absorb miRNAs (miR‐223‐3p and miR‐340‐5p, respectively) to regulate FABP7‐mediated proliferation and progression of these cancer cells.[139, 140]